Cyberport’s incubatee Gense Technologies is the only start-up showcased at the Hong Kong scientific research achievement exhibition of the InnoTech Expo 2022. Gense Technologies self-developed a portable medical imaging device that allows users to conduct scanning of internal organs such as the lungs, liver, and kidneys for images by simply wearing a mediscan belt connected to a dedicated device, replacing traditional invasive scans. This affordable and highly efficient diagnostic innovation enables early, preventive health screening and monitoring at home and clinics. The company has also been commissioned by the Government and universities to follow up with the recovery of COVID-19 patients.
Cyberport has witnessed the birth and development of Gense Technologies’ scientific innovation. In 2017, Gense Technologies became a funded project under the “Cyberport Creative Micro Fund” and joined the “Cyberport Incubation Programme” the next year. With the support of Cyberport, Gense Technologies has flourished and won grand awards in various technology and entrepreneurship competitions. The company has just secured a joint Pre-Series A funding of US$1.8 million which was led by Gobi Ventures and Alibaba Entrepreneurs Fund, and joined by the Cyberport Macro Fund. To date, the team has raised over HK$30 million.
Justin Chan, CEO and Joint Founder of Gense Technologies said, “With the support of Cyberport, various institutions and investors, we have been able to progress our project step by step within a short period of time, and have already achieved the mass production capability required by medical device certification. We have also set out to expand to the huge overseas market and are formulating collaboration with healthcare distributors in more than 20 markets around the world, including private hospital networks, clinic chains, insurance companies, and multinational conglomerates. We will continue to proactively grow our business in the future to provide affordable and convenient health screening and monitoring products for more people.”
The Gense team is composed of 25 doctoral professionals and researchers from Cambridge University, Stanford University and Hong Kong. It is currently coordinating over 10 partnerships with professors on clinical trials and engineering.
Peter Yan, CEO of Cyberport, was thrilled to see Gense Technologies as the only start-up to represent Hong Kong’s achievements over the past 25 years. He hoped that with the support of Cyberport, Gense Technologies would continue to shine and provide affordable medical equipment to the public, so as to make convenience to more people and alleviate the burden on the public health system.
InnoTech Expo 2022 is organised by Our Hong Kong Foundation to showcase Hong Kong’s scientific research achievements since the establishment of the HKSAR 25 years ago, as well as presenting national scientific and technological advancements in aerospace, terrestrial and deep sea arenas.
